Zoran, Velkovski and Maja, Belevska and Emilija, Gjosevska Dastevska (2021) PHARMACOECONOMIC IMPLICATIONS GENERATED BY PRIMARY OPEN-ANGLE GLAUCOMA ON WORKERS. Acta medica medianae, 60 (3). pp. 11-19. ISSN 1821-2794 (Online)
Preview |
Text
Belevska. M..pdf Download (447kB) | Preview |
Abstract
Glaucoma is an optic neuropathy which due to the irreversible loss of visual acuity, the
direct and consequential costs associated with the treatment and the indirect losses because of
the reduced productivity generates social and pharmacoeconomic burdens. The study was
designed to assess pharmacoeconomic implications generated by primary open-angle glaucoma
on workers. It is a cross sectional study, which included 190 male and female respondents with
primary glaucoma, aged 28-67, with visual acuity > 6/18 (0.33), according to the ICD-10
classification, conducted in the period August-November 2020 in North Macedonia. Thirty-four
point twenty one percent of the respondents received low income, 40.53% average and
25.26%, high income. Pharmacological costs for treatment of binocular glaucoma amounted to
24.1-45.4 Euros per month, which accounted for 10.26-19.32% of the respondents’ low income
and < 4.82-9.08% of the respondents’ high income. In 21.05% the economic burden resulted
in existential crisis for the family and 25.79% of the respondents were treated inadequately
with generic alternative medicine or inadequate doses of medication due to financial reasons.
Loss of productivity was registered in 25.79% of the respondents, while 21.58% of whom, due
to their inability to carry out the essential work duties, received lower monthly income.
Glaucoma generates a huge pharmacoeconomic burden, which is a consequence of direct and
other medical costs for treatment and indirect losses from productivity, which requires the use
of screening programs for timely diagnosis and adequate regular treatment, which will help
maintain visual acuity and work ability, thus reducing the pharmacoeconomic burden.
Acta Medica Medianae 2021;60(3):11-19.
Key words: primary glaucoma, pharmacoeconomic implications, treatment, costs,
productivity losses
| Item Type: | Article |
|---|---|
| Subjects: | Scientific Fields (Frascati) > Medical and Health Sciences > Health sciences |
| Divisions: | Higher Medical School |
| Depositing User: | MSc Daniela Petkovska |
| Date Deposited: | 04 Nov 2026 10:59 |
| Last Modified: | 04 Nov 2026 10:59 |
| URI: | https://eprints.uklo.edu.mk/id/eprint/11968 |
Actions (login required)
 |
View Item |